Eleven Biotherapeutics Inc. (EBIO) Rose 7.9% or 0.08 To Price $1.08 On Tuesday


Eleven Biotherapeutics Inc. (EBIO) rose 7.9% or 0.08 to $1.08. It is nearly 1.37 million shares traded, which is 146.81% compare to the average total volume 934155. The market cap of EBIO is $34.35 million. The year to date change is 20.48%. The 52 week price range is from $0.62 to $2.54. Price of EBIO have changed 6.95% during last week. It have changed 20.48% over last month, 42.86% over last 3 months, -10.71% over last 6 months and -47.64% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for EBIO is 0.90. It is -16.67% below current price. The 200-day Moving Averages for EBIO is 1.16. It is 7.41% above current price. The 52-week High is 2.54. It is 135.19% from the current price. The 52-week Low is 0.62. It is -42.59% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of EBIO is 2.16 on 2018-02-15. Short % to float is 7.51%. There are some statistics of EBIO. It is has market cap $34.35 million. The share outstanding is 31.83 million. The average volume is 934155. The revenue is 1.25M. The percent of top 15 Institution holding is 1.80%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of EBIO is -88.92%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of EBIO is -34.26%.


Tags:

Share this post